Sign In
Buy PRPO
$21.65
+0.460 (+2.17%)
At Close: Jul 31, 2026
Precipio Announces Christina Valauri joins the Board of Directors
09:00am, Tuesday, 02'nd Jan 2024
Douglas Fisher, MD will step down as Director, and remain as a board observer Douglas Fisher, MD will step down as Director, and remain as a board observer
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024
04:30pm, Thursday, 14'th Dec 2023
NEW HAVEN, Conn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) shares thoughts and reflections looking back at 2023, and forwa
Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript
06:38pm, Monday, 20'th Nov 2023
Precipio, Inc. (NASDAQ:PRPO ) Q3 2023 Earnings Conference Call November 20, 2023 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Operator Welcome to the Precipio Third Quarter 2
Precipio Announces Q3-2023 Shareholder Update Call
05:00pm, Thursday, 16'th Nov 2023
NEW HAVEN, Conn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2023 corporate update call on November 20th, 2023 at 5:
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022
09:00am, Wednesday, 18'th Oct 2023
NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that Q3-2023 (unaudited) revenues have increased 28% to $4.5M from $3
Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023
10:00am, Tuesday, 03'rd Oct 2023
Company anticipates current cash levels sufficient to reach breakeven Company anticipates current cash levels sufficient to reach breakeven
Precipio Continues to Sign New HemeScreen™ Customers
09:00am, Thursday, 28'th Sep 2023
NEW HAVEN, Conn., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced that new customer orders are expected to bring total Q4 HemeScree
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven
11:00am, Monday, 25'th Sep 2023
Higher pathology revenues and lower cost structure drive down product revenue breakeven point from $8M to $6M Higher pathology revenues and lower cost structure drive down product revenue breakeven po
Precipio Takes Final Step Towards Regaining Nasdaq Compliance
09:00am, Thursday, 21'st Sep 2023
NEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has implemented a 1-for-20 reverse stock split of outs
Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan
09:30am, Wednesday, 13'th Sep 2023
NEW HAVEN, Conn., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces its Pathology Division has in August exceeded the monthly breakeven
Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript
06:32pm, Thursday, 17'th Aug 2023
Precipio, Inc. (NASDAQ:PRPO ) Q2 2023 Earnings Conference Call August 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Second Q
Precipio Announces Q2-2023 Shareholder Update Call
05:00pm, Thursday, 10'th Aug 2023
NEW HAVEN, Conn., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2023 corporate update call on August 17th at 5:00 PM ET
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel
09:00am, Tuesday, 08'th Aug 2023
NEW HAVEN, Conn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces the launch of its new quantitative BCR-ABL 2.0 panel, with features m
Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven
09:00am, Thursday, 03'rd Aug 2023
These efficiencies plus revenue growth expected to continue the positive momentum These efficiencies plus revenue growth expected to continue the positive momentum
Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript
12:34pm, Thursday, 18'th May 2023
Precipio, Inc. (NASDAQ:PRPO ) Q1 2023 Earnings Conference Call May 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Q1 2023 Sha
